Cipla USA, Inc. recalls Budesonide Inhalation Suspension
- Published
- 30 Jul 2025
- Units affected
- 13,680 ampoules
- Agency
- FDA
- Country
- United States
The hazard
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
- Brand / company
- Cipla USA, Inc.
- Codes / lots
- Batch # 4IA0505, Exp 09/31/2026
- Distribution
- Distributed Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.